Kenvue Inc. $KVUE Stock Position Reduced by Swedbank AB

Key Points

• Swedbank AB has reduced its stake in Kenvue Inc. by 6.4%, holding 520,285 shares valued at approximately $10.89 million as of its latest SEC filing.
• Kenvue recently reported an earnings per share of $0.29 for the quarter, slightly beating expectations, but experienced a 4% decline in revenue year-over-year.
• The company has announced a quarterly dividend of $0.2075, increasing from the previous dividend, which results in an annualized yield of 4.5%.

Swedbank AB lessened its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 6.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 520,285 shares of the company's stock after selling 35,400 shares during the period. Swedbank AB's holdings in Kenvue were worth $10,890,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. Evergreen Wealth Solutions LLC increased its holdings in shares of Kenvue by 2.6% in the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock worth $402,000 after acquiring an additional 432 shares during the period. Fulton Bank N.A. increased its holdings in shares of Kenvue by 0.6% in the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after acquiring an additional 465 shares during the period. Scott & Selber Inc. increased its stake in Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after buying an additional 475 shares during the period. Wealth Alliance LLC increased its stake in Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after buying an additional 486 shares during the period. Finally, Everett Harris & Co. CA increased its stake in Kenvue by 1.4% during the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after buying an additional 500 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on KVUE shares. Zacks Research raised shares of Kenvue to a "strong sell" rating in a research note on Monday, August 11th. UBS Group lowered their target price on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Royal Bank Of Canada lowered their target price on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research note on Friday, August 8th. Canaccord Genuity Group lowered their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Finally, Barclays lowered their target price on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Tuesday, July 15th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Kenvue presently has an average rating of "Hold" and an average price target of $24.04.

Kenvue Price Performance

Shares of KVUE traded down $1.38 during mid-day trading on Monday, hitting $16.96. The company's stock had a trading volume of 74,831,635 shares, compared to its average volume of 27,946,758. The firm has a 50-day moving average price of $20.77 and a 200 day moving average price of $22.00. The stock has a market capitalization of $32.55 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 2.63 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. Kenvue Inc. has a fifty-two week low of $16.89 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The business's revenue for the quarter was down 4.0% on a year-over-year basis. During the same period last year, the company posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. This is an increase from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue's payout ratio is 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.